Resistance in vivo of Plasmodium falciparum to co-trimoxazole in western Uganda

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 92, Issue 2, 1998, Pages 197-200

  Kilian, A H D ^a,b   Jelinek, T ^a   Prislin, I ^b   Kabagambe, G ^c   Byamukama, W ^c   Mpigika, G ^d   Korte, R ^e   Von Sonnenburg, F ^b  

^a Gesellschaft für Technische Zusammenarbeit mbH   (Uganda)

^b UNIVERSITY OF MUNICH   (Germany)

^c District Health Services   (Uganda)

^d MINISTRY OF HEALTH   (Uganda)

^e Financial Systems Development Section   (Germany)

Author keywords

Co trimoxazole; Plasmodium falciparum; Sensitivity; Uganda

Indexed keywords

ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; COTRIMOXAZOLE;

ANTIBIOTIC RESISTANCE; ARTICLE; CHILDHOOD DISEASE; CLINICAL TRIAL; FEVER; GEOGRAPHIC DISTRIBUTION; HUMAN; INFANT; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; RESPIRATORY TRACT DISEASE; SYMPTOM; UGANDA; WORLD HEALTH ORGANIZATION;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0031919731     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(98)90748-9     Document Type: Article

References (18)

1. Bloland, P. B., Redd, S. C., Kazembe, P., Tembenu, R., Wirima, J. J. & Campbell, C. C. (1991). Co-trimoxazole for childhood febrile illness in malaria-endemic regions. Lancet, 337, 518-520.
2. Campbell, H., Byass, P., Forgie, I. M., O'Neill, K. P., Lloyd-Evans, N. & Greenwood, B. M. (1988). Trial of co-trimoxazole versus procaine penicillin with ampicillin in treatment of community-acquired pneumonia in young Gambian children. Lancet, ii, 1182-1184.
3. Daramola, O. O., Alonso, P. L., O'Dempsey,T. J. D., Twumasi, P., McArdle, F. & Greenwood, B. M. (1991). Sensitivity of Plasmodium falciparum in The Gambia to co-trimoxazole. Transactions of the Royal Society of Tropical Medicine and Hygiene, 85, 345-348.
4. Dowling, M. A. C. & Shute, G.T. (1966). A comparative study of thick and thin blood films in the diagnosis of scanty malaria parasitaemia. Bulletin of the World Health Organization, 34, 249-267.
5. English, M., Punt, J., Mwangi, I., McHugh, K. & Marsh, K. (1996). Clinical overlap between malaria and severe pneumonia in African children in hospital. Transactions of the Royal Society of Tropical Medicine and Hygiene, 90, 658-662.
6. Fasan, P. O. (1971). Trimethoprim plus sulphamethoxazole compared with chloroquine in the treatment and suppression of malaria in African schoolchildren. Annals of Tropical Medicine and Parasitology, 65, 117-121.
7. Goosen,T. H., Goosen, M. A. L. & Salter, A. J. (1976). A rural study in Tanzania in the chemosuppressant activity of various regimes of co-trimoxazole or chloroquine in subjects with P. falciparum malaria. In: Chemotherapy, volume 6, William, J. D. & Geddes, A. M. (editors). New York: Academic Press, pp. 69-78.
8. Hansford, C. F. & Hoyland, J. (1982). An evaluation of co-trimoxazole in the treatment of Plasmodium falciparum malaria. South African Medical Journal, 61, 512-514.
9. Keeley, D. J., Nkrumah, F. K. & Kapuyanyika, C. (1990). Randomized trial of sulfamethoxazole + trimethoprim versus procaine penicillin for the outpatient treatment of childhood penumonia in Zimbabwe. Bulletin of the World Health Organization, 68, 185-192.
10. Kremsner, P. G., Zotter, G. M., Feldmeier, H., Bienzle, U., Jansen-Rosseck, R., Graninger, W., Rocha, R. M. & Wernsdorfer, W. H. (1989). Differences in drug response of Plasmodium falciparum within an area of the Amazon region. Transactions of the Royal Society of Tropical Medicine and Hygiene, 83, 158-161.
11. Mutabingwa, T. K., Rønn, A. & Bygbjerg, I. C. (1996). Chemotherapeutic efficacy of co-trimoxazole for childhood malaria in an area with multidrug resistance in Tanzania. Transactions of the Royal Society of Tropical Medicine and Hygiene, 90,476 [abstract].
12. O'Dempsey,T. J. D., McArdle, T. F., Laurence, B. E., Lamont, A. C., Todd, J. E. & Greenwood, B. M. (1993). Overlap in the clinical features of pneumonia and malaria in African children. Transactions of the Royal Society of Tropical Medicine and Hygiene, 87, 662-665.
13. Wernsdorfer, W. H. (1994). Epidemiology of drug resistance in malaria. Acta Tropica, 56, 143-156.
14. WHO (1992). The overlap in the clinical presentation and treatment of malaria and pneumonia in children: report of a meeting. Geneva: World Health Organization, mimeographed document WHO/ARI/92.23, WHO/MAL/92,1065.
15. WHO (1994). Antimalaria drug policies: data requirements, treatment of uncomplicated malaria and management of malaria in pregnancy. Geneva: World Health Organization, mimeographed document WHO/MAL/94.1070.
16. WHO (1995). Integrated management of the sick child. Bulletin of the World Health Organization, 73, 735-740.
17. WHO (1996). Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria in areas with intense transmission. Geneva: World Health Organization, mimeographed document WHO/MAL/96,1077.
18. Wolfensberger, H. R. (1970). Clinical trials with Fansidar, Bactrim and chloroquine in 300 cases of acute falciparum malaria. Far East Medical Journal, 6, 48-50.